Kidney Stones And High Levels Of Calcium.
Some tribe who promote recurring kidney stones may also have high-priced levels of calcium deposits in their blood vessels, and that could simplify their increased risk for heart disease, new inspect suggests. "It's becoming clear that having kidney stones is a whit like having raised blood pressure, raised blood lipids such as cholesterol or diabetes in that it is another meter of, or jeopardy factor for, cardiovascular disease and its consequences," said contemplate co-author Dr Robert Unwin, of University College London vimax pra que serve. Unwin is currently premier scientist with the AstraZeneca cardiovascular and metabolic diseases innovative medicines and inopportune circumstance science unit, in Molndal, Sweden.
The main message: "is to begin to establish having kidney stones seriously in correspondence to cardiovascular disease risk, and to practice preventive monitoring and treatments, including subsistence and lifestyle" for more info. Some 10 percent of men and 7 percent of women manifest kidney stones at some idea in their lives, and research has shown that many of these people are at heightened risk for peak blood pressure, chronic kidney disease and love disease, the researchers said.
But study author Dr Linda Shavit, a major nephrologist at Shaare Zedek Medical Center in Jerusalem, and her colleagues wanted to chance out whether the heart issues that can transpire in some of those with kidney stones might be caused by high levels of calcium deposits in their blood vessels. Using CT scans, they looked at calcium deposits in the abdominal aorta, one of the largest blood vessels in the body. Of the 111 nation in the study, 57 suffered recurring kidney stones that were comprised of calcium (kidney stones can be made up of other minerals, depending on the patient's circumstances, the researchers noted), and 54 did not have kidney stones.
Показаны сообщения с ярлыком vessels. Показать все сообщения
Показаны сообщения с ярлыком vessels. Показать все сообщения
понедельник, 22 апреля 2019 г.
воскресенье, 31 января 2016 г.
Promising Transplants Of Blood Vessels For Dialysis Patients
Promising Transplants Of Blood Vessels For Dialysis Patients.
In inappropriate research, blood vessels originating from a donor's crust cells and grown in a laboratory have been successfully implanted in three dialysis patients. These engineered grafts have functioned well for about 8 months, break researchers reporting Monday at a rare online forum sponsored by the American Heart Association vigrx. The three patients - all of whom lived in Poland and were on dialysis for end-stage kidney blight - received the different vessels to consider better access for dialysis.
But the dream is that these types of bioengineered, "off-the-shelf" tissues can someday be hand-me-down as replacement arteries throughout the body, including middle bypass. "The grafts handy now perform quite poorly," said front researcher Todd N McAllister, co-founder and chief manager officer of Cytograft Tissue Engineering Inc, the Novato, California-based maker of the grafts and the funder of the study treatment of garmi in liver at home. Currently, these types of vessels are typically made of fake fabric or they are grafts of the patient's own veins.
In either situation the rate of failure and the need for redoing the procedures remains high. In the unheard of study, giver skin cells were used to grow the blood vessels. The vessels were made from sheets of cultured outside cells, rolled around a ephemeral support structure in the lab.
Upon implantation the vessels typically planned about a foot long and a fifth of an inch in diameter. After implantation, the vessels were occupied as "shunts" between arteries and veins in the arm to gave the resolved access to life-saving dialysis. "To fixture all the grafts are patent functioning well. Perhaps most interestingly, we have seen no clinical manifestations of an protected response".
In inappropriate research, blood vessels originating from a donor's crust cells and grown in a laboratory have been successfully implanted in three dialysis patients. These engineered grafts have functioned well for about 8 months, break researchers reporting Monday at a rare online forum sponsored by the American Heart Association vigrx. The three patients - all of whom lived in Poland and were on dialysis for end-stage kidney blight - received the different vessels to consider better access for dialysis.
But the dream is that these types of bioengineered, "off-the-shelf" tissues can someday be hand-me-down as replacement arteries throughout the body, including middle bypass. "The grafts handy now perform quite poorly," said front researcher Todd N McAllister, co-founder and chief manager officer of Cytograft Tissue Engineering Inc, the Novato, California-based maker of the grafts and the funder of the study treatment of garmi in liver at home. Currently, these types of vessels are typically made of fake fabric or they are grafts of the patient's own veins.
In either situation the rate of failure and the need for redoing the procedures remains high. In the unheard of study, giver skin cells were used to grow the blood vessels. The vessels were made from sheets of cultured outside cells, rolled around a ephemeral support structure in the lab.
Upon implantation the vessels typically planned about a foot long and a fifth of an inch in diameter. After implantation, the vessels were occupied as "shunts" between arteries and veins in the arm to gave the resolved access to life-saving dialysis. "To fixture all the grafts are patent functioning well. Perhaps most interestingly, we have seen no clinical manifestations of an protected response".
Подписаться на:
Комментарии (Atom)